GlassScriptPhysician profile
Sreenivas V Rao
NPI 1942242102
$4,420.11
in general payments reported to CMS, 2019-2025
51 companies · $1,059 in 2025
The $1,059 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $119 · 2021: $271 · 2022: $849 · 2023: $1,049 · 2024: $895 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.36 |
| Education | $222.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $363.95 | 2019-2025 | |
| Novocure Gmbh | $250.00 | 2022 | |
| Astellas Pharma US INC | $234.08 | 2020-2025 | Xtandi, Vyloy |
| Amgen INC. | $218.47 | 2019-2023 | Kyprolis, Vectibix, Xgeva |
| Lilly USA, LLC | $218.13 | 2021-2024 | Jaypirca, Retevmo, Verzenio |
| Celgene Corporation | $217.05 | 2022-2024 | Pomalyst, Reblozyl |
| Merck Sharp & Dohme LLC | $211.12 | 2019-2025 | Keytruda |
| Seagen INC. | $207.30 | 2020-2023 | Tukysa, Padcev, Adcetris |
| Janssen Biotech, INC. | $186.32 | 2023-2025 | Darzalex, Tecvayli, Carvykti |
| Genentech USA, INC. | $141.80 | 2019-2025 | Venclexta, Phesgo, Tecentriq |
| E.R. Squibb & Sons, L.L.C. | $139.32 | 2019-2025 | Opdualag, Opdivo |
| Pfizer INC. | $136.43 | 2023-2025 | |
| Adaptive Biotechnologies Corporation | $115.80 | 2022-2025 | Clonoseq |
| Gilead Sciences, INC. | $113.55 | 2021-2025 | Trodelvy |
| Abbvie INC. | $109.34 | 2021-2024 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $108.92 | 2024 | Cook |
| Intuitive Surgical, INC. | $101.55 | 2025 | |
| Beone Medicines USA, INC. | $98.05 | 2025 | Brukinsa |
| Glaxosmithkline, LLC. | $96.16 | 2022-2025 | Ojjaara, Zejula, Jemperli |
| Takeda Pharmaceuticals U.S.A., INC. | $94.27 | 2022-2025 | Alunbrig, Ninlaro, Fruzaqla |
| Genzyme Corporation | $85.80 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $80.60 | 2022-2025 | Enhertu, Lynparza |
| Daiichi Sankyo INC. | $73.52 | 2021-2025 | Injectafer, Datroway |
| Alexion Pharmaceuticals, INC. | $59.26 | 2022-2024 | Ultomiris |
| Eisai INC. | $51.02 | 2025 | |
| Karyopharm Therapeutics INC. | $50.69 | 2020-2025 | Xpovio |
| Stemline Therapeutics INC. | $50.31 | 2023-2025 | Orserdu |
| Taiho Oncology, INC. | $48.29 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $38.34 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.65 | 2024-2025 | |
| Springworks Therapeutics, INC. | $36.65 | 2024-2025 | Ogsiveo |
| Array Biopharma INC | $33.95 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Exelixis INC. | $33.62 | 2023-2024 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $33.31 | 2023-2025 | Libtayo |
| Legend Biotech USA INC. | $32.63 | 2025 | Carvykti |
| Jazz Pharmaceuticals INC. | $29.18 | 2019-2023 | Zepzelca |
| Aveo Pharmaceuticals, INC. | $26.74 | 2025 | |
| Incyte Corporation | $24.13 | 2024 | Monjuvi, Pemazyre |
| Deciphera Pharmaceuticals INC. | $22.80 | 2025 | Romvimza, Qinlock |
| Beigene USA, INC. | $22.02 | 2024 | Brukinsa |
| Mirati Therapeutics, INC. | $21.73 | 2023 | Krazati |
| Geron Corporation | $21.50 | 2024 | Rytelo |
| Tempus Ai, INC | $20.90 | 2024 | Xt Cdx |
| Pharmacyclics LLC, An Abbvie Company | $18.39 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.82 | 2025 | Danziten |
| Foundation Medicine, INC. | $15.90 | 2022 | |
| G1 Therapeutics, INC. | $15.46 | 2023 | Cosela |
| Sobi, INC | $14.68 | 2024 | |
| Blueprint Medicines Corporation | $14.63 | 2022 | |
| Novocure INC. | $14.32 | 2024 | Optune Lua (Novottf-200t) |
| Rigel Pharmaceuticals, INC. | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreenivas Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.